GBT
AZN icon

Grove Bank & Trust’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$821K Sell
11,752
-937
-7% -$65.5K 0.1% 123
2025
Q1
$933K Buy
12,689
+2,045
+19% +$150K 0.12% 110
2024
Q4
$697K Sell
10,644
-755
-7% -$49.5K 0.1% 128
2024
Q3
$888K Buy
11,399
+378
+3% +$29.5K 0.13% 102
2024
Q2
$860K Hold
11,021
0.14% 97
2024
Q1
$747K Hold
11,021
0.13% 108
2023
Q4
$742K Sell
11,021
-486
-4% -$32.7K 0.14% 114
2023
Q3
$779K Buy
11,507
+339
+3% +$23K 0.16% 112
2023
Q2
$799K Sell
11,168
-89
-0.8% -$6.37K 0.16% 107
2023
Q1
$781K Buy
11,257
+62
+0.6% +$4.3K 0.17% 107
2022
Q4
$759K Sell
11,195
-204
-2% -$13.8K 0.17% 108
2022
Q3
$626K Sell
11,399
-530
-4% -$29.1K 0.16% 114
2022
Q2
$788K Sell
11,929
-14
-0.1% -$925 0.19% 101
2022
Q1
$792K Hold
11,943
0.16% 117
2021
Q4
$696K Hold
11,943
0.13% 127
2021
Q3
$717K Buy
11,943
+12
+0.1% +$720 0.15% 116
2021
Q2
$714K Sell
11,931
-166
-1% -$9.93K 0.15% 121
2021
Q1
$601K Sell
12,097
-116
-0.9% -$5.76K 0.14% 127
2020
Q4
$610K Sell
12,213
-2
-0% -$100 0.16% 117
2020
Q3
$669K Hold
12,215
0.2% 106
2020
Q2
$646K Sell
12,215
-473
-4% -$25K 0.21% 100
2020
Q1
$567K Sell
12,688
-298
-2% -$13.3K 0.22% 96
2019
Q4
$647K Sell
12,986
-1,037
-7% -$51.7K 0.19% 109
2019
Q3
$625K Sell
14,023
-197
-1% -$8.78K 0.2% 111
2019
Q2
$587K Sell
14,220
-3,125
-18% -$129K 0.21% 103
2019
Q1
$701K Sell
17,345
-2,976
-15% -$120K 0.27% 91
2018
Q4
$772K Buy
20,321
+1,052
+5% +$40K 0.36% 68
2018
Q3
$763K Sell
19,269
-306
-2% -$12.1K 0.31% 79
2018
Q2
$687K Buy
19,575
+217
+1% +$7.62K 0.29% 82
2018
Q1
$677K Buy
19,358
+1,973
+11% +$69K 0.3% 85
2017
Q4
$603K Buy
17,385
+546
+3% +$18.9K 0.26% 91
2017
Q3
$571K Buy
16,839
+5,093
+43% +$173K 0.28% 88
2017
Q2
$400K Buy
11,746
+1,348
+13% +$45.9K 0.26% 95
2017
Q1
$324K Buy
10,398
+273
+3% +$8.51K 0.27% 73
2016
Q4
$277K Buy
10,125
+1,350
+15% +$36.9K 0.21% 85
2016
Q3
$288K Buy
8,775
+1,325
+18% +$43.5K 0.25% 81
2016
Q2
$225K Hold
7,450
0.2% 83
2016
Q1
$210K Hold
7,450
0.19% 90
2015
Q4
$253K Buy
+7,450
New +$253K 0.23% 80